Birgitta-A
Fri Feb 6, 2009, 01:27 PM
Hi all,
Within 2009 efficacy and safety of Sapacitabine in a total of approximately 200 patients with leukemias or MDS will be required to provide information for the label in a future submission of a New Drug Application.
http://production.investis.com/cyc/investors/news/pressreleases/2009/2009-02-06/
Kind regards
Birgitta-A
Within 2009 efficacy and safety of Sapacitabine in a total of approximately 200 patients with leukemias or MDS will be required to provide information for the label in a future submission of a New Drug Application.
http://production.investis.com/cyc/investors/news/pressreleases/2009/2009-02-06/
Kind regards
Birgitta-A